Atopic dermatitis or atopic eczema is a chronic, relapsing, familial, symmetric and pruritic inflammatory skin disease that commonly presents during early infancy and childhood, but can persist or start in adulthood.
It is commonly associated with elevated serum immunoglobulin E levels and a personal or family history of allergies, allergic rhinitis and asthma.
It is one of the most common skin diseases afflicting both children and adults.
Serum levels of squamous cell carcinoma antigen 2 (SCCA2) are indicative of disease severity and clinical type of atopic dermatitis (AD), according to a recent study, suggesting that SCCA2 may be a novel and useful marker for evaluating disease activity and treatment efficacy in AD.
There is a significant and disease severity‒dependent increased risk of developing conjunctivitis, keratitis and keratoconus in adults with atopic dermatitis (AD) compared with the general population, according to a recent study.